10x Genomics (TXG) Shares Issued (2018 - 2025)
10x Genomics (TXG) has disclosed Shares Issued for 8 consecutive years, with $2.2 million as the latest value for Q4 2025.
- Quarterly Shares Issued fell 50.37% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.8 million through Dec 2025, down 37.67% year-over-year, with the annual reading at $6.8 million for FY2025, 37.67% down from the prior year.
- Shares Issued hit $2.2 million in Q4 2025 for 10x Genomics, up from $617000.0 in the prior quarter.
- In the past five years, Shares Issued ranged from a high of $16.2 million in Q2 2021 to a low of $156000.0 in Q3 2024.
- Historically, Shares Issued has averaged $4.9 million across 5 years, with a median of $4.6 million in 2024.
- Biggest five-year swings in Shares Issued: plummeted 98.09% in 2021 and later soared 295.51% in 2025.
- Year by year, Shares Issued stood at $8.9 million in 2021, then plummeted by 43.83% to $5.0 million in 2022, then increased by 12.24% to $5.6 million in 2023, then fell by 19.53% to $4.5 million in 2024, then tumbled by 50.37% to $2.2 million in 2025.
- Business Quant data shows Shares Issued for TXG at $2.2 million in Q4 2025, $617000.0 in Q3 2025, and $3.5 million in Q2 2025.